Skip to main content

decentralized clinical trials

By Emily Olsen | 11:54 am | July 21, 2022
The partnership will allow Withings' connected scales, blood pressure monitors and sleep-tracking mats to integrate with Medable's trial platform.
By Emily Olsen | 11:46 am | July 06, 2022
More than 80% of cancer patients and survivors who responded to the survey were willing to use the majority of remote interventions, like oral medications delivered to the home, electronic informed consent and wearables.
By Emily Olsen | 11:25 am | May 05, 2022
The round included a strategic investment from pharma giant Gilead Sciences to expand their partnership for decentralized and hybrid trials.
By Emily Olsen | 01:19 pm | April 21, 2022
Reify said it will use the investment to focus its tools on increased diversity in clinical trials.
By Emily Olsen | 12:45 pm | April 19, 2022
This marks THREAD's third recent acquisition, including the inVibe deal announced early this year and the Modus Outcomes purchase from November.
By Emily Olsen | 02:19 pm | October 07, 2021
Also: Decentralized clinical trial platform Lightship raises $40 million, and digital pediatric clinic Brave Care scooped up $25 million.
By Emily Olsen | 12:55 pm | September 15, 2021
The platform allows for image collection and management from multisite trials and the homes of study participants.
By Nathan Eddy | 11:16 am | August 18, 2021
The platform has served as the basis of clinical research studies at multiple institutions, including UCSF and Stanford University.
By MobiHealthNews | 03:03 pm | May 21, 2021
THREAD Research CEO John Reites speaks on the state of remote and hybrid trials, and how COVID-19 has accelerated an already blossoming field.
By Skip Fleshman | 12:19 pm | January 22, 2021
Asset Management Ventures' Skip Fleshman outlines COVID-19's impact on clinical trials and the resulting leap toward tech-enabled decentralized trials.